Will health be good for your wealth?

Set up your individual savings account now and you can maximise your returns

With six months left to invest this year's tax-free allowance of £7,000 in an individual savings account (ISA), you may be thinking that you've got plenty of time to get round to it.

With six months left to invest this year's tax-free allowance of £7,000 in an individual savings account (ISA), you may be thinking that you've got plenty of time to get round to it.

But it is worth remembering that, statistically, those investors who put regular amounts into an ISA over the year get better returns. And those who buy their ISAs on the eve of the 5 April deadline get less for their money as the price is inflated by the surge of interest from other investors.

So with this in mind, which funds are attracting investors this year? Technology remains popular, despite the volatility of the sector (see opposite page). But healthcare is predicted to be the big growth story this year and in the future.

Much of this interest is down to the success of the project to map the human genome (the blueprint for the established 200,000 different genes that create a human being), which was finished several years ahead of schedule. Drugs can now be tailored to individuals to make them more effective. Biotechnology and healthcare are undeniably highly speculative, but just think what would happen to the share price of a company that discovered a cure for cancer.

"Unlike dot coms, these companies are creating tangible, sellable products," says Donna Bradshaw, director at independent financial adviser (IFA) Fiona Price & Partners. "There is quite a lot of confidence in the sector, although it is not for the faint-hearted."

While general European and North American ISAs often have some exposure to biotech and medical companies, specialist healthcare funds are being launched in response to increased demand. Unfortunately, as some of these funds are so new, they have no track record.

"You can't say with a new fund how good the performance is going to be," says Ms Bradshaw. "It might be worth taking a punt. But you should do a lot of homework, look at the underlying investments and bear in mind how long the manager has studied this type of investment."

Framlington Healthcare is one of the best-established funds in the sector. It was launched in 1987 and its manager, Antony Milford, has been involved with the fund since then.

"In this particular sector, that expertise is very important," says Framlington's marketing manager, Lesley Hankin. "[The sector] is hugely specialised and he knows it inside out and backwards."

The fund is available as an ISA, and has £400m in assets under management. But even though it is long-established, it is highly volatile. In the past 12 months (to year ending 1 September), however, it rose by 228.2 per cent, topping the specialist fund sector, according to Money Management magazine.

Fidelity Investments has just launched four new funds concentrating on different sectors, one of which invests in healthcare (the others are financial, industrial and consumer). Brigitte Ascher, fund analyst at Fidelity, believes that the healthcare industry has great growth potential for investors. "It is expected to increase its revenues due to the fact that the population is ageing," she says. "Older people need more drugs and more looking after from a healthcare point of view, so spending will continue to rise."

Ms Ascher also points out that the discovery of blockbuster, or money-making, drugs is expected to increase over the next few years, with quite a few currently in the pipeline. According to figures from Merrill Lynch, a total of seven block-buster drugs will be launched this year, doubling to 14 next year and 17 the year after.

The fragmentation of the healthcare sector, coupled with the rising costs of research and development, means that there are also likely to be a number of mergers in the industry - which can be good news for investors.

When Glaxo Smith-Kline completes its merger, becoming the biggest pharmaceutical company in the world, it will still capture just 7 per cent of the overall market, with many much smaller companies having a tiny stake.

Depending on their exposure to biotechnology, some funds are riskier than others. Investors should look at their underlying investments carefully. Framlington Healthcare, for example, opts for big pharmaceutical firms and invests only partly in biotechnology stocks. The Schroder Medical Discovery fund opts for mainly healthcare with a few biotech companies thrown in, as does Flemings' Global Life Sciences. Franklin Biotechnology, available from Edinburgh-based fund manager Templeton, invests exclusively in biotech.

Whichever fund you choose, bear in mind that it should form only part of your overall portfolio because of the high-risk factor. Only if you have a broad spread of investments in other sectors and countries, should you look at healthcare, and even then, you should be prepared to tie your money up for 10 years or so.

"Keep your head on your shoulders and don't get carried away with short-term gains," says Ms Bradshaw. "Then you won't make the mistake people did with technology, in going for the fast buck. It is wise to keep the bulk of your money in less speculative funds."

* Contacts: Fidelity, 0800 414161; Flemings, 0500 500324; Framlington Group, 0345 775511; Schroders, 0800 718777; Templeton, 0131 228 3932.

Independent Partners; Do you need financial advice on your investments, pension or insurance? Book a free consultation with an independent Financial Adviser at VouchedFor.co.uk

Arts and Entertainment
Louis Theroux: By Reason of Insanity takes him behind the bars again
tvBy Reason of Insanity, TV review
Arts and Entertainment
Cassetteboy's latest video is called Emperor's New Clothes rap
videoThe political parody genius duo strike again with new video
Sport
Seth Rollins cashes in his Money in the Bank contract to win the WWE World Heavyweight Championship
WWERollins win the WWE World Heavyweight title in one of the greatest WrestleMania's ever seen
Arts and Entertainment
Jim Davidson performs his comedy show at Edinburgh Festival 2014
TV
Finacial products from our partners
Property search
  • Get to the point
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating
and  

By clicking 'Search' you
are agreeing to our
Terms of Use.

ES Rentals

    iJobs Job Widget
    iJobs Money & Business

    Recruitment Genius: Retirement Coordinator - Financial Services

    Negotiable: Recruitment Genius: To provide a prompt, friendly and efficient se...

    Recruitment Genius: Annuities / Pensions Administrator

    Negotiable: Recruitment Genius: You will be the first point of contact for all...

    Ashdown Group: HR, Payroll & Benefits Officer - Altrincham - up to £24,000.

    £18000 - £24000 per annum + benefits: Ashdown Group: HR, Payroll & Benefits Of...

    Ashdown Group: Learning and Development Programme Manager

    £35000 - £38000 per annum + benefits : Ashdown Group: A highly successful, int...

    Day In a Page

    No postcode? No vote

    Floating voters

    How living on a houseboat meant I didn't officially 'exist'
    Louis Theroux's affable Englishman routine begins to wear thin

    By Reason of Insanity

    Louis Theroux's affable Englishman routine begins to wear thin
    Power dressing is back – but no shoulderpads!

    Power dressing is back

    But banish all thoughts of Eighties shoulderpads
    Spanish stone-age cave paintings 'under threat' after being re-opened to the public

    Spanish stone-age cave paintings in Altamira 'under threat'

    Caves were re-opened to the public
    'I was the bookies’ favourite to be first to leave the Cabinet'

    Vince Cable interview

    'I was the bookies’ favourite to be first to leave the Cabinet'
    Election 2015: How many of the Government's coalition agreement promises have been kept?

    Promises, promises

    But how many coalition agreement pledges have been kept?
    The Gaza fisherman who built his own reef - and was shot dead there by an Israeli gunboat

    The death of a Gaza fisherman

    He built his own reef, and was fatally shot there by an Israeli gunboat
    Saudi Arabia's airstrikes in Yemen are fuelling the Gulf's fire

    Saudi airstrikes are fuelling the Gulf's fire

    Arab intervention in Yemen risks entrenching Sunni-Shia divide and handing a victory to Isis, says Patrick Cockburn
    Zayn Malik's departure from One Direction shows the perils of fame in the age of social media

    The only direction Zayn could go

    We wince at the anguish of One Direction's fans, but Malik's departure shows the perils of fame in the age of social media
    Young Magician of the Year 2015: Meet the schoolgirl from Newcastle who has her heart set on being the competition's first female winner

    Spells like teen spirit

    A 16-year-old from Newcastle has set her heart on being the first female to win Young Magician of the Year. Jonathan Owen meets her
    Jonathan Anderson: If fashion is a cycle, this young man knows just how to ride it

    If fashion is a cycle, this young man knows just how to ride it

    British designer Jonathan Anderson is putting his stamp on venerable house Loewe
    Number plates scheme could provide a licence to offend in the land of the free

    Licence to offend in the land of the free

    Cash-strapped states have hit on a way of making money out of drivers that may be in collision with the First Amendment, says Rupert Cornwell
    From farm to fork: Meet the Cornish fishermen, vegetable-growers and butchers causing a stir in London's top restaurants

    From farm to fork in Cornwall

    One man is bringing together Cornwall's most accomplished growers, fishermen and butchers with London's best chefs to put the finest, freshest produce on the plates of some of the country’s best restaurants
    Robert Parker interview: The world's top wine critic on tasting 10,000 bottles a year, absurd drinking notes and New World wannabes

    Robert Parker interview

    The world's top wine critic on tasting 10,000 bottles a year, absurd drinking notes and New World wannabes
    Don't believe the stereotype - or should you?

    Don't believe the stereotype - or should you?

    We exaggerate regional traits and turn them into jokes - and those on the receiving end are in on it too, says DJ Taylor